| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |